252 related articles for article (PubMed ID: 10727458)
1. Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer.
Koopman LA; Corver WE; van der Slik AR; Giphart MJ; Fleuren GJ
J Exp Med; 2000 Mar; 191(6):961-76. PubMed ID: 10727458
[TBL] [Abstract][Full Text] [Related]
2. HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines.
Koopman LA; Mulder A; Corver WE; Anholts JD; Giphart MJ; Claas FH; Fleuren GJ
Tissue Antigens; 1998 Jun; 51(6):623-36. PubMed ID: 9694355
[TBL] [Abstract][Full Text] [Related]
3. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
[TBL] [Abstract][Full Text] [Related]
4. Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression.
Keating PJ; Cromme FV; Duggan-Keen M; Snijders PJ; Walboomers JM; Hunter RD; Dyer PA; Stern PL
Br J Cancer; 1995 Aug; 72(2):405-11. PubMed ID: 7640226
[TBL] [Abstract][Full Text] [Related]
5. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.
Feenstra M; Veltkamp M; van Kuik J; Wiertsema S; Slootweg P; van den Tweel J; de Weger R; Tilanus M
Tissue Antigens; 1999 Sep; 54(3):235-45. PubMed ID: 10519360
[TBL] [Abstract][Full Text] [Related]
6. Frequent HLA class I loss is an early event in cervical carcinogenesis.
Vermeulen CF; Jordanova ES; Zomerdijk-Nooijen YA; ter Haar NT; Peters AA; Fleuren GJ
Hum Immunol; 2005 Nov; 66(11):1167-73. PubMed ID: 16571417
[TBL] [Abstract][Full Text] [Related]
7. High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity.
Rodriguez T; Méndez R; Roberts CH; Ruiz-Cabello F; Dodi IA; López Nevot MA; Paco L; Maleno I; Marsh SG; Pawelec G; Garrido F
Cancer Immunol Immunother; 2005 Feb; 54(2):141-8. PubMed ID: 15592718
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite analysis of microdissected tumor cells and 6p high density microsatellite analysis in head and neck squamous cell carcinomas with down-regulated human leukocyte antigen class I expression.
Feenstra M; Verdaasdonk M; van der Zwan AW; de Weger R; Slootweg P; Tilanus M
Lab Invest; 2000 Mar; 80(3):405-14. PubMed ID: 10744076
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the immune escape phenotype of human gastric cancers with and without high-frequency microsatellite instability.
Hirata T; Yamamoto H; Taniguchi H; Horiuchi S; Oki M; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Apr; 211(5):516-523. PubMed ID: 17318812
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity at 6p21 underlying [corrected] HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas.
Yang Y; Zhang J; Miao F; Wei J; Shen C; Shen Y; Xie W
Tissue Antigens; 2008 Aug; 72(2):105-14. PubMed ID: 18721270
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity at 6p21 and HLA class I expression in esophageal squamous cell carcinomas in China.
Zhao X; Sun Q; Tian H; Cong B; Jiang X; Peng C
Asian Pac J Cancer Prev; 2011; 12(10):2741-5. PubMed ID: 22320985
[TBL] [Abstract][Full Text] [Related]
12. Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers.
Ryu KS; Lee YS; Kim BK; Park YG; Kim YW; Hur SY; Kim TE; Kim IK; Kim JW
Exp Mol Med; 2001 Sep; 33(3):136-44. PubMed ID: 11642549
[TBL] [Abstract][Full Text] [Related]
13. Human leukocyte antigen class I gene mutations in cervical cancer.
Koopman LA; van Der Slik AR; Giphart MJ; Fleuren GJ
J Natl Cancer Inst; 1999 Oct; 91(19):1669-77. PubMed ID: 10511595
[TBL] [Abstract][Full Text] [Related]
14. Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts.
Masuda K; Hiraki A; Fujii N; Watanabe T; Tanaka M; Matsue K; Ogama Y; Ouchida M; Shimizu K; Ikeda K; Tanimoto M
Cancer Sci; 2007 Jan; 98(1):102-8. PubMed ID: 17083564
[TBL] [Abstract][Full Text] [Related]
15. Human leukocyte antigen class II alleles and risk of cervical cancer in China.
Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Lin Z; Xu A
Hum Immunol; 2007 Mar; 68(3):192-200. PubMed ID: 17349874
[TBL] [Abstract][Full Text] [Related]
16. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
[TBL] [Abstract][Full Text] [Related]
17. Distinction between HLA class I-positive and -negative cervical tumor subpopulations by multiparameter DNA flow cytometry.
Corver WE; Koopman LA; Mulder A; Cornelisse CJ; Fleuren GJ
Cytometry; 2000 Sep; 41(1):73-80. PubMed ID: 10942899
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression.
Jimenez P; Cantón J; Concha A; Cabrera T; Fernández M; Real LM; García A; Serrano A; Garrido F; Ruiz-Cabello F
Cancer Immunol Immunother; 2000 Mar; 48(12):684-90. PubMed ID: 10752476
[TBL] [Abstract][Full Text] [Related]
19. Frequency and genetic basis of MHC, beta-2-microglobulin and MEMO-1 loss of heterozygosity in sporadic breast cancer.
McEvoy CR; Seshadri R; Morley AA; Firgaira FA
Tissue Antigens; 2002 Sep; 60(3):235-43. PubMed ID: 12445306
[TBL] [Abstract][Full Text] [Related]
20. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
